Skip to main content
SpringerLink
Log in

Ivacaftor recommended by Canadian Drug Expert Committee

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cystic Fibrosis Canada. Cystic Fibrosis Canada Welcomes Common Drug Review Recommendation for KALYDECO. Media Release : 26 Mar 2013. Available from: URL: http://www.cysticfibrosis.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ivacaftor recommended by Canadian Drug Expert Committee. PharmacoEcon Outcomes News 675, 11 (2013). https://doi.org/10.1007/s40274-013-0300-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0300-2

Search

Navigation